Cargando…

Comment to: Propofol and survival: an updated meta-analysis of randomized clinical trials

Detalles Bibliográficos
Autores principales: Benavides-Zora, David, Arias-Botero, Jose Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207798/
https://www.ncbi.nlm.nih.gov/pubmed/37226253
http://dx.doi.org/10.1186/s13054-023-04489-4
_version_ 1785046533336465408
author Benavides-Zora, David
Arias-Botero, Jose Hugo
author_facet Benavides-Zora, David
Arias-Botero, Jose Hugo
author_sort Benavides-Zora, David
collection PubMed
description
format Online
Article
Text
id pubmed-10207798
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102077982023-05-25 Comment to: Propofol and survival: an updated meta-analysis of randomized clinical trials Benavides-Zora, David Arias-Botero, Jose Hugo Crit Care Comment BioMed Central 2023-05-24 /pmc/articles/PMC10207798/ /pubmed/37226253 http://dx.doi.org/10.1186/s13054-023-04489-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Comment
Benavides-Zora, David
Arias-Botero, Jose Hugo
Comment to: Propofol and survival: an updated meta-analysis of randomized clinical trials
title Comment to: Propofol and survival: an updated meta-analysis of randomized clinical trials
title_full Comment to: Propofol and survival: an updated meta-analysis of randomized clinical trials
title_fullStr Comment to: Propofol and survival: an updated meta-analysis of randomized clinical trials
title_full_unstemmed Comment to: Propofol and survival: an updated meta-analysis of randomized clinical trials
title_short Comment to: Propofol and survival: an updated meta-analysis of randomized clinical trials
title_sort comment to: propofol and survival: an updated meta-analysis of randomized clinical trials
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207798/
https://www.ncbi.nlm.nih.gov/pubmed/37226253
http://dx.doi.org/10.1186/s13054-023-04489-4
work_keys_str_mv AT benavideszoradavid commenttopropofolandsurvivalanupdatedmetaanalysisofrandomizedclinicaltrials
AT ariasboterojosehugo commenttopropofolandsurvivalanupdatedmetaanalysisofrandomizedclinicaltrials